#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal atresia Enteritis Pelizaeus-Merzbacher disease Angiosarcoma recurrent Hereditary angioedema with C1 esterase inhibitor deficiency Mycobacterium abscessus infection Porphyria non-acute Acquired C1 inhibitor deficiency Glomerulonephritis rapidly progressive Neurotrophic keratopathy Rectal cancer Fungal infection Human papilloma virus immunisation Cholangiosarcoma Autologous haematopoietic stem cell transplant More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Treatment Familial amyotrophic lateral sclerosis – Treatment Netherton’s syndrome – Diagnostics Atypical haemolytic uraemic syndrome – Basic Information Lennox-Gastaut syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Testicular leiomyosarcoma – Basic Information Metachromatic leukodystrophy – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Systemic sclerosis pulmonary – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ponsegromab Bupivacaine Hydrochloride GRISNILIMAB SETARITOX ADX-038 Sodium Sulfate Anhydrous Litifilimab Ticagrelor Codeine Phosphate Hemihydrate Bisacodyl Potassium Oxybate Acp-017 Mk-1942 Topotecan F44/10 Ferrous Sulfate Tropicamide TRIGLYCERIDES MEDIUM CHAIN Festuca Rubra Pollen Tazobactam Idarubicin More therapies…

    Learn about Your Condition

    Myotonia Hyperadrenocorticism Extraskeletal ossification Vulvar dysplasia Brain stem glioma Head and neck cancer stage IV Electronic cigarette user Hypereosinophilic syndrome Acne Bronchostenosis Muscular dystrophy Vascular dementia Vertigo Ligament sprain Lyme disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Rituximab for Patients with Rheumatoid Arthritis: Comparing 200 mg and 1g Doses for Maintenance Treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    France

  • Study on Obinutuzumab for Patients with Relapsing Granulomatosis with Polyangiitis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Obinutuzumab
    France

  • Study of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • NADOFARAGENE FIRADENOVEC
    Czechia Denmark France Italy Poland Spain

  • Study on the Safety and Effectiveness of Short Dual Antiplatelet Therapy with Ticagrelor, Clopidogrel, and Prasugrel in Patients Aged 65+ with Coronary Artery Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clopidogrel
    • D,L-Lysine Acetylsalicylate
    • Prasugrel
    France

  • Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Etavopivat
    Belgium France Greece Italy The Netherlands Spain

  • Study on the Effectiveness of Cemiplimab, Carboplatin, and Paclitaxel for Unfit or Elderly Patients with Unresectable Stage III Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Carboplatin
    • Cemiplimab
    • Paclitaxel
    France

  • Study on the Safety and Immune Response of the 20-Valent Pneumococcal Vaccine in Adults with Fever and High Risk for Pneumococcal Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197
    • Pneumococcal Polysaccharide Serotype 12F Conjugated To Crm197
    France

  • Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

    Recruiting

    3 1
    Investigated Drugs:
    • TIFCEMALIMAB
    • Toripalimab
    Belgium France Germany Italy The Netherlands Poland +2

  • Study of EG-70 for Patients with Non-Muscle Invasive Bladder Cancer Unresponsive to BCG or High-Risk Patients New to BCG or with Incomplete BCG Treatment

    Recruiting

    2 1 1
    Investigated Drugs:
    • Lauromacrogol 400
    France Germany Italy Spain

  • Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Humanised Igg4 Kappa Monoclonal Antibody Against Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl6, Cxcl7 And Cxcl8
    • Mirikizumab
    Belgium Croatia Czechia Denmark France Germany +8
Previous Page
1 … 5 6 7 8 9 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!